Rate My Professor Miroslaw Janowski

Dr. Janowski's research centers on molecular imaging and precision medicine in neurointerventions, emphasizing radiolabeling and magnetic labeling of therapeutic agents for central nervous system delivery via real-time interventional PET and MR imaging, enhancements to blood-brain barrier opening, and CRISPR-based genome editing, with related patents pending. Active projects encompass image-guided intra-arterial delivery of antibodies to the CNS (NIH/NINDS, $1,931,250), Warfighter Brain Health (Geneva Foundation, $678,871), hyperpolarized 13C metabolic imaging in ischemic stroke models (NIH/NINDS, $424,875), computational approaches to in vivo brain genome editing (Maryland Stem Cell Research Fund, $350,000), and nanogel radiocarrier labeling for T cell PET imaging in tumors (American Cancer Society, $297,000), totaling over $3.6 million in funding. With 194 publications amassing more than 7,400 citations, key works include "Concise review: mesenchymal stem cells: from roots to boost" (Stem Cells, 2019; 730 citations), "Mesenchymal stem cells for neurological disorders" (Advanced Science, 2021; 384 citations), "Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles" (Journal of Neuroinflammation, 2019; 331 citations), and "Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles" (Frontiers in Immunology, 2021; 303 citations). He holds the role of Associate Editor for Frontiers in Neuroscience and contributes to public lectures and committee roles in organizations like the Society for Image Guided Neurointerventions.